Valeant Pharmaceuticals International

États‑Unis d’Amérique


 
Quantité totale PI 18
Quantité totale incluant filiales 46 (+ 28 pour les filiales)
Rang # Quantité totale PI 82 927
Note d'activité PI 0/5.0    0
Rang # Activité PI 1 661 163
Parent Bausch Health Companies, Inc.
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

1 3
0 0
10 0
4
 
Dernier brevet 2014 - Silicone gel-based compositions ...
Premier brevet 2004 - Use of ribofuranose derivatives ...
Dernière marque 2015 - VALEANT
Première marque 1999 - KINERASE

Filiales

5 subsidiaries with IP (25 patents, 3 trademarks)

2 subsidiaries without IP

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2015 P/S food supplements.
2013 Invention Silicone gel-based compositions for wound healing and scar reduction. This invention is a composi...
2012 Invention Benzyloxy anilide derivatives useful as potassium channel modulators. The present invention relat...
2011 Invention Derivatives of 4-(n-azacycloalkyl) aniilides as potassium channel modulators. This invention prov...
Invention Modified release formulation and methods of use. A modified release pharmaceutical formulation in...
2008 Invention Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassi...
Invention Naphthyridine derivatives as potassium channel modulators. This invention provided compounds of f...
Invention 3-hydroxyisothiazole-4-carboxamidine derivatives as chk2 inhibitors. This invention provides comp...
Invention Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators. This invention provi...
2007 Invention 1,4 diamino bicyclic retigabine analogues as potassium channel modulators. This invention is dire...
2006 Invention Phenylamino isothiazole carboxamidines as mek inhibitors. The invention concerns compounds of for...
2005 P/S House mark for a full line of pharmaceutical preparations and dermatological products. Research a...
2004 Invention Use of ribofuranose derivatives against inflammatory bowel diseases. A method for the prophylax...
P/S house mark for a full line of pharmaceutical preparations and dermatological pharmaceutical products
P/S house mark for a full line of pharmaceutical preparations and dermatological products
P/S A full line of pharmaceutical preparations and dermatological products. Research and development ...
2003 P/S House mark for a full line of pharmaceutical preparations and dermatological products for humans
1999 P/S Cosmetics, skin cream and lotion, body cream and lotion, and facial cream and lotion.